| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/21/2010 | WO2008109519A3 Micro-rna profiles associated with endometrial cancer |
| 01/21/2010 | WO2006039470A9 Anti- amyloid antibodies, compositions, methods and uses |
| 01/21/2010 | WO2005074521A9 C-TERMINAL p53 PALINDROMIC PEPTIDE THAT INDUCES APOPTOSIS OF CELLS WITH ABERRANT p53 AND USES THEREOF |
| 01/21/2010 | WO2004041170A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2004024097A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2003106635A9 Functional sites |
| 01/21/2010 | WO2003057859A9 Genes for altering mitochondrial function and for hybrid seed production |
| 01/21/2010 | WO2002078642A9 Differentially-expressed and up-regulated polynucleotides and polypeptides in breast cancer |
| 01/21/2010 | US20100017918 Arabidopsis derived promoters for regulation of plant expression |
| 01/21/2010 | US20100017917 Transgenic plants with tocopherol methyltransferase |
| 01/21/2010 | US20100017915 Manipulation of Plant Polysaccharide Synthases |
| 01/21/2010 | US20100017914 Insecticidal proteins |
| 01/21/2010 | US20100017912 Compositions and methods using rna interference of cad-like genes for control of nematodes |
| 01/21/2010 | US20100017910 Compositions and Methods Using RNA Interference of CDPK-Like For Control of Nematodes |
| 01/21/2010 | US20100017909 Nitrate transport components |
| 01/21/2010 | US20100017902 Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof |
| 01/21/2010 | US20100017901 Compositions Comprising MG29 Nucleic Acids, Polypeptides, and Associated Methods of Use |
| 01/21/2010 | US20100017896 Filaggrin |
| 01/21/2010 | US20100016574 2'-Hydroxyl Group-Modified Ribonucleoside Derivatives |
| 01/21/2010 | US20100016573 siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) |
| 01/21/2010 | US20100016572 Derived from the N-terminal domain of the serine-repeat antigen produced by the malaria parasite, Plasmodium falciparum; can be produced in Escherichia coli on a large scale by deleting all or part of polymerized serines of the 47 kd serine-repeat region; inhibit fever and cerebral malaria |
| 01/21/2010 | US20100016571 Peptide having ability to activate cancer-related gene |
| 01/21/2010 | US20100016570 Modified family 6 glycosidases with altered substrate specificity |
| 01/21/2010 | US20100016569 Cellomics system |
| 01/21/2010 | US20100016568 Cellomics system |
| 01/21/2010 | US20100016567 Process for producing di(pyrimidine nucleoside 5'-)polyphosphate |
| 01/21/2010 | US20100016566 Method of synthesizing cdna and method of synthesizing rna chains, and nucleotide-immobilized carrier |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016553 Internalization |
| 01/21/2010 | US20100016545 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement |
| 01/21/2010 | US20100016431 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition |
| 01/21/2010 | US20100016416 Oligonucleotide Conjugates |
| 01/21/2010 | US20100016409 Rna Nanoparticles and Nanotubes |
| 01/21/2010 | US20100016406 Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration |
| 01/21/2010 | US20100016405 Compositions and Methods for Inhibiting Expression of the MYC Gene |
| 01/21/2010 | US20100016276 Compositions and methods for the identification of a carbapenemase gene |
| 01/21/2010 | US20100016253 Methods and compositions related to heightened apobec-1 related protein (arp) expression |
| 01/21/2010 | US20100016177 Templated molecules and methods for using such molecules |
| 01/21/2010 | US20100016176 siRNA targeting histamine receptor H1 |
| 01/21/2010 | US20100016172 Nucleic acid binding assay materials and methods |
| 01/21/2010 | US20100015725 Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides |
| 01/21/2010 | US20100015708 Ribonucleic acids with non-standard bases and uses thereof |
| 01/21/2010 | US20100015707 SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION |
| 01/21/2010 | US20100015706 Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof |
| 01/21/2010 | US20100015701 Novel fluorescent proteins and methods for using same |
| 01/21/2010 | US20100015700 Use of the adenoviral e2 late promoter |
| 01/21/2010 | US20100015698 Human Chondroitinase Glycoprotein (CHASEGP), Process for Preparing the Same, and Pharmaceutical Compositions Comprising Thereof |
| 01/21/2010 | US20100015681 Hydrogen Production By Means Of A Cell Expression System |
| 01/21/2010 | US20100015666 Isothermal dna amplification |
| 01/21/2010 | US20100015654 Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells |
| 01/21/2010 | US20100015631 Concatameric ligation products: compositions methods and kits for same |
| 01/21/2010 | US20100015627 Selection method |
| 01/21/2010 | US20100015620 Cancer-linked genes as biomarkers to monitor response to impdh inhibitors |
| 01/21/2010 | US20100015618 Dna fragment used as attached to 5' end of primer used in nucleic acid amplification reaction and use of dna fragment |
| 01/21/2010 | US20100015608 Binary deoxyribozyme probes for nucleic acid analysis |
| 01/21/2010 | US20100015607 Nanoreporters and methods of manufacturing and use thereof |
| 01/21/2010 | US20100015604 Composition and method for determination of ck19 expression |
| 01/21/2010 | US20100015599 Isolated reductive dehalogenase genes |
| 01/21/2010 | US20100015319 Precise breeding - low acrylamide foods |
| 01/21/2010 | US20100015232 Nanoparticles for nucleic acid delivery |
| 01/21/2010 | US20100015170 Flagellin mutant vaccine |
| 01/21/2010 | US20100015168 Immunogenic compositions for streptococcus agalactiae |
| 01/21/2010 | US20100015153 Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the Same |
| 01/21/2010 | US20100015150 Tdf-related compounds and analogs thereof |
| 01/21/2010 | US20100015135 Anti-ephb4 antibodies and methods using same |
| 01/21/2010 | US20100015133 Methods for Producing Polypeptides by Regulating Polypeptide Association |
| 01/21/2010 | US20100015131 Composition Comprising Antibodies to LINGO or Fragments Thereof |
| 01/21/2010 | US20100015120 Hybrid protein that converts arachidonic acid into prostacyclin |
| 01/21/2010 | US20100015117 Compositions and methods for targeting a polypeptide to the central nervous system |
| 01/21/2010 | US20100015113 Gp100-specific t cell receptors and related materials and methods of use |
| 01/21/2010 | US20100015107 Expression elements |
| 01/21/2010 | US20100015101 Novel tumor antigen peptides |
| 01/21/2010 | US20100015096 Fusion Proteins of Mycobacterium Tuberculosis |
| 01/21/2010 | US20100015056 Uranium-chelating peptides and uses thereof |
| 01/21/2010 | US20100015041 Class of Supramolecular Drug Molecules and Methods of Identification and Use Thereof |
| 01/21/2010 | US20100012495 Set of Novel Oligonucleotide Primers and the Method for the Detection of Aspergillus Ochraceux Thereby |
| 01/21/2010 | US20100011654 Rnai for the control of insects and arachnids |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2728467A1 Compositions and methods for inhibiting expression of tgf-beta receptor genes |
| 01/20/2010 | EP2145965A1 Multiplex quantification of nucleic acids in diseased cells |
| 01/20/2010 | EP2145963A1 Enhanced sequencing by hybridization using pools of probes |
| 01/20/2010 | EP2145955A2 Bead emulsion nucleic acid amplification |
| 01/20/2010 | EP2145897A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/20/2010 | EP2144922A2 Isolated nucleic acid molecules corresponding to micro rna 145 (mirna-145) and their use in treating colon cancer |
| 01/20/2010 | EP1922420B1 METHOD AND SUBSTANCES FOR ISOLATING miRNAs |
| 01/20/2010 | EP1257649B1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/20/2010 | CN100582117C Compositions for DNA mediated gene silencing |
| 01/19/2010 | US7649088 Diagnosis and treatment of Hereditary Spastic Paraplegia |
| 01/19/2010 | US7649084 Genetic engineering; cat thyrotropin beta -subunit polypeptide and polynucleotide; hyperthyroidism |
| 01/19/2010 | US7648964 In response to an insult or injury, in protecting against ocular inflammation, and in promoting ocular wound repair; glycoprotein |
| 01/19/2010 | US7648963 Molecules of the PYRIN/NBS/LRR protein family and uses thereof |
| 01/19/2010 | US7648708 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 01/19/2010 | CA2123492C Lymphoid antigen cd30 |
| 01/14/2010 | WO2010006342A2 Compositions and methods for inhibiting expression of gsk-3 genes |
| 01/14/2010 | WO2010006173A2 Mineral amino acid polysaccharide complex |
| 01/14/2010 | WO2010006071A1 Hvem/btla, hvem/cd160 and hvem/gd cis complexes and methods of use |
| 01/14/2010 | WO2010005055A1 Oligonucleotide structure, and method for regulation of gene expression |
| 01/14/2010 | WO2010004054A2 Construction of cell penetrating nucleic acids |
| 01/14/2010 | WO2009143391A3 Methods for modulation expression of creb |
| 01/14/2010 | WO2009143390A3 Methods for modulating expression of rbp4 |